EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer

Kirollos Hanna, Kelley Mayden

Journal of the Advanced Practitioner in Oncology · 01.03.2021 · 12 (2)

DOI: 10.6004/jadpro.2021.12.2.12 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 01.03.2021. Verfasst von Kirollos Hanna und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic and M Health Fairview, Rochester, Minnesota. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Almost all patients with breast cancer will eventually receive chemotherapy drugs, the majority of which are administered as IV infusions. Real-world evidence indicates that while current treatment paradigms vary considerably from guideline recommendations, there is an increasing trend towards a preference for oral oncolytics among patients with breast cancer. Recent data have shown that oral anticancer therapeutics represent 25% of the oncology drug market share and that there is a high demand for these agents. Therefore, oral formulations of chemotherapy agents such as paclitaxel are currently under development. Although oral oncolytics are associated with several advantages over conventional intravenous drugs, maintaining adherence to therapy is a major barrier in achieving improved outcomes with these agents. Advanced practitioners can facilitate improved adherence to oral oncolytics by integrating evidence into practice to support better education and communication strategies to address patient concerns, overcome key hurdles, and ultimately, empower patients.

Autor:innen und Institutionen

  • Mayo Clinic and M Health Fairview, Rochester, Minnesota.
  • Ballad Health Cancer Care-Bristol, Bristol, Tennessee.

Zitieren

APA

Hanna, K., & Mayden, K. (2021). The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer. Journal of the Advanced Practitioner in Oncology, 12(2). https://doi.org/10.6004/jadpro.2021.12.2.12

Vancouver

Hanna K, Mayden K. The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer. Journal of the Advanced Practitioner in Oncology. 2021;12(2). doi:10.6004/jadpro.2021.12.2.12

BibTeX
@article{Hanna2021,
  author = {Hanna, Kirollos and Mayden, Kelley},
  title = {The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer},
  journal = {Journal of the Advanced Practitioner in Oncology},
  year = {2021},
  volume = {12},
  number = {2},
  doi = {10.6004/jadpro.2021.12.2.12}
}
Kostenlos starten →